U.S. Department of EnergyOffice of Scientific and Technical Information
COVID-19 Drug Discovery Dataset
- Authors:
-
- Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States); LLNL
- Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
- Publication Date:
- Other Number(s):
- LLNL-MI-835726
IM # 1053637
- DOE Contract Number:
- AC52-07NA27344
- Research Org.:
- LLNL-IPO (LLNL Innovation and Partnerships Office (IPO))
- Sponsoring Org.:
- USDOE National Nuclear Security Administration (NNSA)
- OSTI Identifier:
- 1969494
- DOI:
- https://doi.org/10.11578/1608139
Citation Formats
Kim, Hyojin, and Allen, Jonathan. COVID-19 Drug Discovery Dataset. United States: N. p., 2022.
Web. doi:10.11578/1608139.
Kim, Hyojin, & Allen, Jonathan. COVID-19 Drug Discovery Dataset. United States. doi:https://doi.org/10.11578/1608139
Kim, Hyojin, and Allen, Jonathan. 2022.
"COVID-19 Drug Discovery Dataset". United States. doi:https://doi.org/10.11578/1608139. https://www.osti.gov/servlets/purl/1969494. Pub date:Sun May 01 04:00:00 UTC 2022
@article{osti_1969494,
title = {COVID-19 Drug Discovery Dataset},
author = {Kim, Hyojin and Allen, Jonathan},
abstractNote = {},
doi = {10.11578/1608139},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Sun May 01 04:00:00 UTC 2022},
month = {Sun May 01 04:00:00 UTC 2022}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.